EPTINEZUMAB (Vyepti®)

Clinical Indication

For the prophylaxis of migraine in adults who have at least 4 migraine days per month.

Comments

In line with NICE TA871

Date of classification

January 2023

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.